Abstract
The 2020 American Cancer Society cervical cancer screening guidelines call for a shift to primary human papillomavirus testing every 5 years, with cotesting and cytology alone acceptable where primary testing platforms are not available. Initiation of screening is recommended at the age of 25 years instead of 21 years.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
